1. Search Result
Search Result
Results for "

Clopidogrel-MP endo derivative-<sup>13</sup>C,d<sub>3</sub>

" in MedChemExpress (MCE) Product Catalog:

100

Inhibitors & Agonists

8

Screening Libraries

7

Fluorescent Dye

4

Biochemical Assay Reagents

1

MCE Kits

23

Recombinant Proteins

18

Isotope-Labeled Compounds

21

Antibodies

37

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-133781

    Clopidogrel-MP-AM

    Drug Metabolite Others
    cis-Clopidogrel-MP derivative (Clopidogrel-MP-AM) is a 3’-methoxyacetophenone derivative of Clopidogrel active metabolite . Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor .
    cis-Clopidogrel-MP derivative
  • HY-15876

    Drug Metabolite P2Y Receptor Cardiovascular Disease
    Clopidogrel thiolactone is an important intermediate in the metabolism of clopidogrel (HY-15283). Clopidogrel thiolactone has antiplatelet aggregatione effects. Clopidogrel is a P2Y12 receptor inhibitor that exerts antiplatelet effects .
    Clopidogrel thiolactone
  • HY-E70132

    endo D

    Glycosidase Metabolic Disease
    Endo-β-N-acetylglucosaminidase D (Endo D), isolated from Streptococcus pneumoniae. Endo-β-N-acetylglucosaminidase D hydrolyzes Fc N-glycan of intact IgG antibodies after sequential removal of the sialic acid, galactose, and internal GlcNAc residues in the N-glycan. Endo-β-N-acetylglucosaminidase D possesses transglycosylation activity with sugar oxazoline as the donor substrate .
    Endo-β-N-acetylglucosaminidase D
  • HY-E70133

    endo F2

    Others Metabolic Disease
    Endo-β-N-acetylglucosaminidase F2 (Endo F2), a highly specific endoglycosidase, cleaves within the chitobiose core of asparagine-linked complex biantennary and high mannose oligosaccharides from glycoproteins and glycopeptides. Endo F2 cleaves biantennary glycans at a rate approximately 20 times greater than high mannose glycans. The activity of Endo F2 is identical on biantennary structures with and without core fucosylation. Endo F2 is not active on hybrid or tri- and tetra-antennary oligosaccharides .
    Endo-β-N-acetylglucosaminidase F2
  • HY-E70134

    endo F3

    Others Metabolic Disease
    Endo-β-N-acetylglucosaminidase D (Endo F3) cleaves free or Asparagine-linked triantennary oligosaccharides or α1-6 fucosylated biantennary oligosaccharides, as well as triamnnosyl chitobiose core structures .
    Endo-β-N-acetylglucosaminidase F3
  • HY-E70131

    endo-β-N-acetylglucosaminidase H

    Others Metabolic Disease
    Endo H, Streptomyces picatus (Endo-β-N-acetylglucosaminidase H), isolated from Streptomyces plicatus, hydrolyzes the central glycosidic bond of the β1, 4-di-N-acetylchitobiose core in asparagine-linked oligosaccharides .
    Endo H, Streptomyces picatus
  • HY-Z2483S

    Isotope-Labeled Compounds Others
    Clopidogrel-MP endo derivative- 13C,d3 is the deuterium and 13C labeled Clopidogrel-MP endo derivative .
    Clopidogrel-MP endo derivative-13C,d3
  • HY-141749AS

    CLPM-d<sub>4sub>; SR 26334-d<sub>4sub>

    Isotope-Labeled Compounds Cardiovascular Disease
    Clopidogrel carboxylic acid-d4 is a deuterated derivative of Clopidogrel carboxylic acid, which is an inactive metabolite of the antiplatelet agent Clopidogrel (HY-15283) in plasma. Clopidogrel carboxylic acid-d4 can be used to further explore the metabolic characteristics of Clopidogrel .
    Clopidogrel carboxylic acid-d4
  • HY-17459S

    (S)-(+)-Clopidogrel bisulfate-d<sub>3sub>; (S)-(+)-Clopidogrel-d<sub>3sub> hydrogen sulfate

    P2Y Receptor Cytochrome P450 Cardiovascular Disease
    Clopidogrel-d3 (hydrogen sulfate) is the deuterium labeled Clopidogrel hydrogen sulfate . Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation.Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor .
    Clopidogrel-d3 hydrogen sulfate
  • HY-15283AS

    (±)-Clopidogrelum-d<sub>7sub> sulfate

    P2Y Receptor Isotope-Labeled Compounds Others
    (±)-Clopidogrel-d7 (sulfate) is the deuterium labeled (±)-Clopidogrel sulfate .
    (±)-Clopidogrel-d7 sulfate
  • HY-17459
    Clopidogrel hydrogen sulfate
    20+ Cited Publications

    (S)-(+)-Clopidogrel bisulfate; (S)-(+)-Clopidogrel hydrogen sulfate

    Cytochrome P450 P2Y Receptor Cardiovascular Disease Cancer
    Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively . Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation [2].Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor .
    Clopidogrel hydrogen sulfate
  • HY-17459R

    (S)-(+)-Clopidogrel bisulfate (Standard); (S)-(+)-Clopidogrel hydrogen sulfate (Standard)

    Reference Standards Cytochrome P450 P2Y Receptor Cardiovascular Disease Cancer
    Clopidogrel (hydrogen sulfate) (Standard) is the analytical standard of Clopidogrel (hydrogen sulfate). This product is intended for research and analytical applications. Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively . Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation [2].Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor .
    Clopidogrel hydrogen sulfate (Standard)
  • HY-110043

    P2Y Receptor Cardiovascular Disease
    (±)-Clopidogrel hydrochloride is an antithrombotic agent that is ADP-selective and orally available. (±)-Clopidogrel hydrochloride inhibits platelet aggregation by inhibiting the binding of ADP to its platelet receptors .
    (±)-Clopidogrel hydrochloride
  • HY-143817S

    Isotope-Labeled Compounds Others
    Clopidogrel-d3 (hydrochloride) is the deuterium labeled Clopidogrel hydrochloride .
    Clopidogrel-d3 hydrochloride
  • HY-141749S

    (Rac)-CLPM-d<sub>4sub>; (Rac)-SR 26334-d<sub>4sub>

    Isotope-Labeled Compounds Others
    (Rac)-Clopidogrel carboxylic acid-d4 is the deuterium labeled (Rac)-Clopidogrel carboxylic acid .
    (Rac)-Clopidogrel carboxylic acid-d4
  • HY-W011114

    P2Y Receptor Cardiovascular Disease
    Clopidogrel-related Compound B hydrochloride is an impurity of Clopidogrel (HY-15283).
    Clopidogrel-related Compound B hydrochloride
  • HY-107867

    P2Y Receptor Cardiovascular Disease Inflammation/Immunology
    (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects .
    (±)-Clopidogrel bisulfate
  • HY-107867S

    Isotope-Labeled Compounds Others
    Clopidogrel-d4 (sulfate) is the deuterium labeled Clopidogrel sulfate .
    Clopidogrel-d4 sulfate
  • HY-15283R

    Clopidogrelum (Standard)

    Reference Standards P2Y Receptor Cardiovascular Disease Cancer
    Clopidogrel (Standard) is the analytical standard of Clopidogrel. This product is intended for research and analytical applications. Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
    Clopidogrel (Standard)
  • HY-W744340

    Isotope-Labeled Compounds Others
    2-Oxo Clopidogrel-d3 is the deuterium labeled (±)-2-Oxo clopidogrel (HY-118025). (±)-2-Oxo clopidogrel is a metabolite of the antiplatelet agent Clopidogrel (HY-15283) .
    2-Oxo Clopidogrel-d3
  • HY-15283
    Clopidogrel
    20+ Cited Publications

    Clopidogrelum

    P2Y Receptor Cardiovascular Disease Cancer
    Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor. Clopidogrel is used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.
    Clopidogrel
  • HY-107867S3

    Isotope-Labeled Compounds Others
    (Rac)-Clopidogrel-d3 (sulfate) is deuterium labeled Clopidogrel (sulfate).
    (Rac)-Clopidogrel-d3 sulfate
  • HY-141749B

    CLPM hydrochloride; SR 26334 hydrochloride

    Drug Metabolite Cardiovascular Disease
    Clopidogrel carboxylic acid (CLPM) hydrochloride is an inactive metabolite of the widely used antiplatelet medication clopidogrel, which serves as a reference standard for quantitative analysis of clopidogrel metabolism. Clopidogrel carboxylic acid hydrochloride has been shown to represent approximately 85% of circulating clopidogrel, hydrolyzed from the active form by esterases. Clopidogrel carboxylic acid hydrochloride plays a crucial role in assessing the pharmacokinetics and bioavailability of clopidogrel in various clinical and research settings.
    Clopidogrel carboxylic acid hydrochloride
  • HY-141530

    Drug Metabolite Cytochrome P450 Cardiovascular Disease Cancer
    Clopidogrel-β-D-glucuronide is a metabolite of Clopidogrel (HY-15283). Clopidogrel-β-D-glucuronide directly interacts with CYP2C8 enzyme and strongly inhibits the liver enzyme CYP2C8 .
    Clopidogrel-β-D-glucuronide
  • HY-E70070

    Bacterial Others
    Endo-β-N-acetylglucosaminidase (Endo A) is an Endo-β-N-acetylglucosaminidases (ENGases) from Arthrobacter protophormiae. Endo-β-N-acetylglucosaminidase (Endo A) can transfer a high-mannose type oligosaccharide to monosaccharides such as N-acetylglucosamine (GlcNAc) and glucose to form a new oligosaccharide. Endo-β-N-acetylglucosaminidase (Endo A) catalyzes glycopeptide synthesis by using Man3GlcNAc-oxazoline .
    Endo-β-N-acetylglucosaminidase (Endo A)
  • HY-118025

    (±)-SR-121683

    Drug Metabolite Others
    (±)-2-Oxo clopidogrel is a metabolite of the antiplatelet agent Clopidogrel (HY-15283) .
    (±)-2-Oxo clopidogrel
  • HY-154761S

    Isotope-Labeled Compounds Others
    Clopidogrel- 13C,d5 hydrochloride is 13C and deuterated labeled Clopidogrel.
    Clopidogrel-13C,d5 hydrochloride
  • HY-150528S

    Isotope-Labeled Compounds Others
    rac-Clopidogrel Amide-d4 is the deuterium labeled rac-Clopidogrel Amide .
    rac-Clopidogrel Amide-d4
  • HY-149033

    Others Cancer
    Kobusine derivative-2, a kobusine derivative, has antiproliferative activity against cancer cells. Kobusine derivative-2 can induce the arrest of MDA-MB-231 cells in the sub-G1 phase. Anticancer activity .
    Kobusine derivative-2
  • HY-118025R

    (±)-SR-121683 (Standard)

    Drug Metabolite Reference Standards Others
    (±)-2-Oxo clopidogrel (Standard) is the analytical standard of (±)-2-Oxo clopidogrel. This product is intended for research and analytical applications. (±)-2-Oxo clopidogrel is a metabolite of the antiplatelet agent Clopidogrel (HY-15283) .
    (±)-2-Oxo clopidogrel (Standard)
  • HY-107867S1

    Isotope-Labeled Compounds P2Y Receptor Inflammation/Immunology
    (Rac)-Clopidogrel hydrogen-d9 sulfate is the deuterium labeled (±)-Clopidogrel (bisulfate) (HY-107867). (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects .
    (Rac)-Clopidogrel hydrogen-d9 sulfate
  • HY-107867S2

    Isotope-Labeled Compounds P2Y Receptor Cardiovascular Disease
    Clopidogrel- 13C,d3 sulfate is the deuterium and 13C-labeled (±)-Clopidogrel (bisulfate) (HY-107867). (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects .
    Clopidogrel-13C,d3 sulfate
  • HY-E70068

    Others Others
    Endo-β-N-acetylglucosaminidase (Endo S) is a family 18 glycosyl hydrolase secreted by Streptococcus pyogenes. Endo-β-N-acetylglucosaminidase (Endo S) exclusively hydrolyzes the β-1,4-di-N-acetylchitobiose core of the asparagine-linked complex-type glycan on Asn-297 of the γ-chains of IgG antibody .
    Endo-β-N-acetylglucosaminidase (Endo S)
  • HY-141749A

    CLPM; SR 26334

    Endogenous Metabolite Metabolic Disease
    Clopidogrel carboxylic acid (CLPM) is the inactive liver metabolite of anti platelet agent, Clopidogrel (HY-15283), in human serum .
    Clopidogrel carboxylic acid
  • HY-155327

    Fluorescent Dye Others
    Cy3-PEG2-endo-BCN is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing 2 PEG units. Cy3-PEG2-endo-BCN contains the lyophilic bidentate macrocyclic ligand endo-BCN, which can further synthesize macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.
    Cy3-PEG2-endo-BCN
  • HY-149618

    Fluorescent Dye Others
    Cy5-PEG3-endo-BCN is a dye derivative of Cyanine 5 (Cy5) (HY-D0821) containing 3 PEG units. Cy5-PEG3-endo-BCN contains the lyophilic bidentate macrocyclic ligand endo-BCN, which can further synthesize macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.
    Cy5-PEG3-endo-BCN
  • HY-149619

    Fluorescent Dye Others
    Cy5-PEG7-endo-BCN is a dye derivative of Cyanine 5 (Cy5) (HY-D0821) containing 7 PEG units. Cy5-PEG7-endo-BCN contains the lyophilic bidentate macrocyclic ligand endo-BCN, which can further synthesize macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.
    Cy5-PEG7-endo-BCN
  • HY-W778270

    Isotope-Labeled Compounds Others
    2-Oxo clopidogrel- 13C,d3 hydrochloride is the deuterium and 13C-labeled (±)-2-Oxo clopidogrel hydrochloride (HY-W585947).
    2-Oxo clopidogrel-13C,d3 hydrochloride
  • HY-E70135

    endo F1

    Endogenous Metabolite Metabolic Disease
    Endo-β-N-acetylglucosaminidase F1 (Endo F1) cleaves Asparagine-linked high mannose and some hybrid oligosaccharides .
    Endo-β-N-acetylglucosaminidase F1
  • HY-155327B

    Fluorescent Dye Others
    Cy3-PEG2-endo-BCN bromide is the bromide salt form of Cy3-PEG2-endo-BCN (HY-155327). Cy3-PEG2-endo-BCN bromide is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing 2 PEG units. Cy3-PEG2-endo-BCN bromide contains the lyophilic bidentate macrocyclic ligand endo-BCN, which can further synthesize macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts .
    Cy3-PEG2-endo-BCN bromide
  • HY-172664A

    Drug Derivative Cancer
    Trabectedin derivative 2 TFA (compound PL-12) is a Trabectedin derivative that can be used for the study of cancer .
    Trabectedin derivative 2 TFA
  • HY-176256

    STING Cancer
    endo-S-cGAFMP (Compound 3) is a STING agonist. endo-S-cGAFMP induces the production of interferon regulatory factors and proinflammatory cytokines by activating the cGAS-STING pathway, thereby enhancing innate and adaptive immune responses. endo-S-cGAFMP has potent immunostimulatory capacity in THP1 monocytes and RAW macrophages (EC50 values of 2.45 μM and 5.54 μM, respectively). endo-S-cGAFMP has significant antitumor activity. endo-S-cGAFMP can be used as a potential cancer immunotherapeutic agent, especially for studies of systemic administration .
    endo-S-cGAFMP
  • HY-D2121

    Fluorescent Dye Others
    Cy3-PEG7-endo-BCN is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing 7 PEG units. Cy3-PEG7-endo-BCN contains the lyophilic bidentate macrocyclic ligand BCN, which can further synthesize macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.
    Cy3-PEG7-endo-BCN
  • HY-D2120

    Fluorescent Dye Others
    Cy3-PEG3-endo-BCN is a dye derivative of Cyanine 3 (Cy3) (HY-D0822) containing 3 PEG units. Cy3-PEG3-endo-BCN contains the lyophilic bidentate macrocyclic ligand BCN, which can further synthesize macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.
    Cy3-PEG3-endo-BCN
  • HY-P3004

    Lyticase

    Endogenous Metabolite Fungal Infection
    Endo-1,3-β-glucanase (Lyticase) is an endoenzyme that can specifically cleave β-1,3-glycosidic bonds. Endo-1,3-β-glucanase recognizes and binds to β-1,3-glucan chains, catalyzing the cleavage of glycosidic bonds and hydrolyzing polysaccharides into oligosaccharides. Endo-1,3-β-glucanase eliminates vaginal Candida. Endo-1,3-β-glucanase can be used in the study of recurrent Candida vaginitis .
    Endo-1,3-β-glucanase
  • HY-E70069

    Others Others
    Endo-β-N-acetylglucosaminidase (Endo S2) is a key enzyme involved in the processing of free oligosaccharides in the cytosol. Endo-β-N-acetylglucosaminidase catalyzes hydrolysis of N-linked oligosaccharides .
    Endo S2, Streptococcus pyogenes
  • HY-15876R

    Drug Metabolite Reference Standards P2Y Receptor Cardiovascular Disease
    Cyhalofop (Standard) is the analytical standard of Cyhalofop. This product is intended for research and analytical applications. Cyhalofop (Cyhalofop acid), the primary metabolite of Cyhalofop-butyl (HY-B0861) in susceptible grasses, is the herbicidally active metabolite. Cyhalofop-butyl is an aryloxyphenoxypropionate post-emergence herbicide widely used around the world in agriculture .
    Clopidogrel thiolactone (Standard)
  • HY-W035129

    Biochemical Assay Reagents Others
    endo-BCN-NHS carbonate is an elastin-like protein (ELP) modification reagent. endo-BCN-NHS carbonate can react with lysine residues in ELP to make ELP carry BCN groups, and then cross-link ELP through strain-promoted azide-alkyne cycloaddition (SPAAC) reaction. endo-BCN-NHS carbonate promotes hydrogel formation. endo-BCN-NHS carbonate is mainly used in cell encapsulation related research .
    endo-BCN-NHS carbonate
  • HY-E70069GL

    Biochemical Assay Reagents Others
    Endo S2, Streptococcus pyogenes (GMP Like) is Endo S2, Streptococcus pyogenes (HY-E70069) produced by using GMP like guidelines. Endo-β-N-acetylglucosaminidase (Endo S2) is a key enzyme involved in the processing of free oligosaccharides in the cytosol. Endo-β-N-acetylglucosaminidase catalyzes hydrolysis of N-linked oligosaccharides .
    Endo S2, Streptococcus pyogenes (GMP Like)
  • HY-156317

    ADC Linker Cancer
    BCN-endo-PEG7-maleimide is an ADC Linker containing 7 PEG units. BCN-endo-PEG7-maleimide contains the lyophilic bidentate macrocyclic ligand endo-BCN, which can further synthesize macrocyclic complexes. In click chemistry, endo-BCN can react with molecules containing azide groups to form stable triazoles in the absence of catalysts.
    BCN-endo-PEG7-maleimide

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: